Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HRness in Breast and Ovarian Cancers.

International journal of molecular sciences - 28 May 2020

Santana Dos Santos Elizabeth, Lallemand François, Petitalot Ambre, Caputo Sandrine M, Rouleau Etienne

Abstract excerpt

Ovarian and breast cancers are currently defined by the main pathways involved in the tumorigenesis. The majority are carcinomas, originating from epithelial cells that are in constant division and subjected to cyclical variations of the estrogen stimulus during the female hormonal cycle, therefore being vulnerable to DNA damage. A portion of breast and ovarian carcinomas arises in the context of DNA repair...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Cell Cycle
Share to DNA Damage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Homologous Recombination

Share to Ovarian Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32481735
DOI: 10.3390/ijms21113850
PMCID: PMC7312125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HRness in Breast and Ovarian Cancers.PMID 32481735Read ↗

BRCAness: Finding the Achilles Heel in Ovarian CancerSemantic proximity Read ↗

Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition TestingSemantic proximity Read ↗

Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer.Semantic proximity Read ↗

Homologous Recombination Deficiency in Ovarian and Breast Cancers: Biomarkers, Diagnosis and TreatmentSemantic proximity Read ↗

DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic OpportunitiesSemantic proximity Read ↗

Homologous recombination deficiency in breast cancer: Implications for risk, cancer development, and therapySemantic proximity Read ↗

The biological effects and clinical implications of BRCA mutations: where do we go from here?Semantic proximity Read ↗

Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genesSemantic proximity Read ↗

Homologous Recombination Defects and Mutations in DNA Damage Response (DDR) Genes Besides BRCA1 and BRCA2 as Breast Cancer Biomarkers for PARP Inhibitors and Other DDR Targeting Therapies.Semantic proximity Read ↗

Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.Semantic proximity Read ↗

Mechanism and significance of chromosome damage repair by homologous recombinationSemantic proximity Read ↗

DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy OutcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.